Trial Profile
Prospective, randomised, double-blind, placebo-controlled, single centre phase IIa clinical trial to investigate the safety and tolerability as well as the impact of a substitution of sexual hormones with an estrogen-progestin combination over 10 weeks in addition to in-house psychotherapy on neuro-endocrinological parameters, psychopathology and neuro-psychological performance compared to in-house psychotherapy alone in adult females with anorexia nervosa
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 31 Jan 2019
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/dienogest (Primary)
- Indications Anorexia nervosa
- Focus Therapeutic Use
- Acronyms HOSAN
- 26 Jan 2019 Status changed from recruiting to discontinued.
- 09 Mar 2016 New trial record